Submitted by Anonymous (not verified) on 27 March 2026 - 11:38
Orphan designation: Leniolisib Treatment of activated phosphoinositide 3-kinase delta syndrome, 19/10/2020 Positive
Source:
Orphan designation: Leniolisib Treatment of activated phosphoinositide 3-kinase delta syndrome, 19/10/2020 Positive